Regulus Therapeutics
RGLS
#8846
Rank
NZ$0.15 B
Marketcap
$2.40
Share price
0.00%
Change (1 day)
6.02%
Change (1 year)

EPS for Regulus Therapeutics (RGLS)

EPS in 2023 (TTM): -$2.78

According to Regulus Therapeutics's latest financial reports the company's current EPS (TTM) is -$2.90. In 2022 the company made an earnings per share (EPS) of -$3.19 an increase over its 2021 EPS that were of -$5.60.

EPS history for Regulus Therapeutics from 2012 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.78-12.76%
2022-$3.19-43.12%
2021-$5.60-40.55%
2020-$9.42-50%
2019-$18.85-80.36%
2018-$95.96-57.8%
2017-$227.40-28.66%
2016-$318.7342.2%
2015-$224.14-14.84%
2014-$263.21156%
2013-$102.82-98.75%
2012-$8,228

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$6.00-307.14%๐Ÿ‡ฌ๐Ÿ‡ง UK
$5.45-288.18%๐Ÿ‡ซ๐Ÿ‡ท France
$31.63-1,192.31%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.40-217.46%๐Ÿ‡ฌ๐Ÿ‡ง UK
-$7.04 143.20%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.47-14.79%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.80-334.91%๐Ÿ‡บ๐Ÿ‡ธ USA